Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes
Translationally controlled tumor protein (TCTP) regulates several cellular processes, including apoptosis, and is overexpressed in several cancer types. Here, the authors report that high levels of TCTP are associated with poor response to anti-PD-L1 and that TCTP targeting increases the efficacy of...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-022-29611-y |